These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 35757841)

  • 1. Mitochondrial phosphoenolpyruvate carboxykinase promotes tumor growth in estrogen receptor-positive breast cancer via regulation of the mTOR pathway.
    Hsu HP; Chu PY; Chang TM; Huang KW; Hung WC; Jiang SS; Lin HY; Tsai HJ
    Cancer Med; 2023 Jan; 12(2):1588-1601. PubMed ID: 35757841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial phosphoenolpyruvate carboxykinase (PEPCK-M) is a pro-survival, endoplasmic reticulum (ER) stress response gene involved in tumor cell adaptation to nutrient availability.
    Méndez-Lucas A; Hyroššová P; Novellasdemunt L; Viñals F; Perales JC
    J Biol Chem; 2014 Aug; 289(32):22090-102. PubMed ID: 24973213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial phosphoenolpyruvate carboxykinase (PEPCK-M) regulates the cell metabolism of pancreatic neuroendocrine tumors (pNET) and de-sensitizes pNET to mTOR inhibitors.
    Chu PY; Jiang SS; Shan YS; Hung WC; Chen MH; Lin HY; Chen YL; Tsai HJ; Chen LT
    Oncotarget; 2017 Nov; 8(61):103613-103625. PubMed ID: 29262588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial Phosphoenolpyruvate Carboxykinase Regulates Metabolic Adaptation and Enables Glucose-Independent Tumor Growth.
    Vincent EE; Sergushichev A; Griss T; Gingras MC; Samborska B; Ntimbane T; Coelho PP; Blagih J; Raissi TC; Choinière L; Bridon G; Loginicheva E; Flynn BR; Thomas EC; Tavaré JM; Avizonis D; Pause A; Elder DJ; Artyomov MN; Jones RG
    Mol Cell; 2015 Oct; 60(2):195-207. PubMed ID: 26474064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysregulation of phosphoenolpyruvate carboxykinase in cancers: A comprehensive analysis.
    Xue S; Cai Y; Liu J; Ji K; Yi P; Long H; Zhang X; Li P; Song Y
    Cell Signal; 2024 Aug; 120():111198. PubMed ID: 38697449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PCK2 activation mediates an adaptive response to glucose depletion in lung cancer.
    Leithner K; Hrzenjak A; Trötzmüller M; Moustafa T; Köfeler HC; Wohlkoenig C; Stacher E; Lindenmann J; Harris AL; Olschewski A; Olschewski H
    Oncogene; 2015 Feb; 34(8):1044-50. PubMed ID: 24632615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The glycerol backbone of phospholipids derives from noncarbohydrate precursors in starved lung cancer cells.
    Leithner K; Triebl A; Trötzmüller M; Hinteregger B; Leko P; Wieser BI; Grasmann G; Bertsch AL; Züllig T; Stacher E; Valli A; Prassl R; Olschewski A; Harris AL; Köfeler HC; Olschewski H; Hrzenjak A
    Proc Natl Acad Sci U S A; 2018 Jun; 115(24):6225-6230. PubMed ID: 29844165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PEPCK Coordinates the Regulation of Central Carbon Metabolism to Promote Cancer Cell Growth.
    Montal ED; Dewi R; Bhalla K; Ou L; Hwang BJ; Ropell AE; Gordon C; Liu WJ; DeBerardinis RJ; Sudderth J; Twaddel W; Boros LG; Shroyer KR; Duraisamy S; Drapkin R; Powers RS; Rohde JM; Boxer MB; Wong KK; Girnun GD
    Mol Cell; 2015 Nov; 60(4):571-83. PubMed ID: 26481663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low expression of PCK2 in breast tumors contributes to better prognosis by inducing senescence of cancer cells.
    Ma X; Gao Y; Liu J; Xu L; Liu W; Huna A; Wang X; Gong W
    IUBMB Life; 2022 Sep; 74(9):896-907. PubMed ID: 35580079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphoenolpyruvate from Glycolysis and PEPCK Regulate Cancer Cell Fate by Altering Cytosolic Ca
    Moreno-Felici J; Hyroššová P; Aragó M; Rodríguez-Arévalo S; García-Rovés PM; Escolano C; Perales JC
    Cells; 2019 Dec; 9(1):. PubMed ID: 31861674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PEPCK-M expression in mouse liver potentiates, not replaces, PEPCK-C mediated gluconeogenesis.
    Méndez-Lucas A; Duarte JA; Sunny NE; Satapati S; He T; Fu X; Bermúdez J; Burgess SC; Perales JC
    J Hepatol; 2013 Jul; 59(1):105-13. PubMed ID: 23466304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of mitochondrial phosphoenolpyruvate carboxykinase with prognosis and immune regulation in hepatocellular carcinoma.
    Li C; Zhang ED; Ye Y; Xiao Z; Huang H; Zeng Z
    Sci Rep; 2024 Jun; 14(1):14051. PubMed ID: 38890507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PEPCK-M recoups tumor cell anabolic potential in a PKC-ζ-dependent manner.
    Hyroššová P; Aragó M; Moreno-Felici J; Fu X; Mendez-Lucas A; García-Rovés PM; Burgess S; Figueras A; Viñals F; Perales JC
    Cancer Metab; 2021 Jan; 9(1):1. PubMed ID: 33413684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution and prognostic significance of gluconeogenesis and glycolysis in lung cancer.
    Smolle E; Leko P; Stacher-Priehse E; Brcic L; El-Heliebi A; Hofmann L; Quehenberger F; Hrzenjak A; Popper HH; Olschewski H; Leithner K
    Mol Oncol; 2020 Nov; 14(11):2853-2867. PubMed ID: 32777161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The phosphoenolpyruvate carboxykinase (PEPCK) inhibitor, 3-mercaptopicolinic acid (3-MPA), induces myogenic differentiation in C2C12 cells.
    Brearley MC; Daniel ZCTR; Loughna PT; Parr T; Brameld JM
    Sci Rep; 2020 Dec; 10(1):22177. PubMed ID: 33335245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycosylation defects, offset by PEPCK-M, drive entosis in breast carcinoma cells.
    Hyroššová P; Aragó M; Muñoz-Pinedo C; Viñals F; García-Rovés PM; Escolano C; Méndez-Lucas A; Perales JC
    Cell Death Dis; 2022 Aug; 13(8):730. PubMed ID: 36002449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A plant/fungal-type phosphoenolpyruvate carboxykinase located in the parasite mitochondrion ensures glucose-independent survival of
    Nitzsche R; Günay-Esiyok Ö; Tischer M; Zagoriy V; Gupta N
    J Biol Chem; 2017 Sep; 292(37):15225-15239. PubMed ID: 28726641
    [No Abstract]   [Full Text] [Related]  

  • 18. Intricate Regulation of Phosphoenolpyruvate Carboxykinase (PEPCK) Isoforms in Normal Physiology and Disease.
    Seenappa V; Joshi MB; Satyamoorthy K
    Curr Mol Med; 2019; 19(4):247-272. PubMed ID: 30947672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mitochondrial isoform of phosphoenolpyruvate carboxykinase (PEPCK-M) and glucose homeostasis: has it been overlooked?
    Stark R; Kibbey RG
    Biochim Biophys Acta; 2014 Apr; 1840(4):1313-30. PubMed ID: 24177027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacology and preclinical validation of a novel anticancer compound targeting PEPCK-M.
    Aragó M; Moreno-Felici J; Abás S; Rodríguez-Arévalo S; Hyroššová P; Figueras A; Viñals F; Pérez B; Loza MI; Brea J; Latorre P; Carrodeguas JA; García-Rovés PM; Galdeano C; Ginex T; Luque FJ; Escolano C; Perales JC
    Biomed Pharmacother; 2020 Jan; 121():109601. PubMed ID: 31739159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.